Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells

被引:44
|
作者
Hettinga, JVE
Lemstra, W
Meijer, C
Dam, WA
Uges, DRA
Konings, AWT
DeVries, EGE
Kampinga, HH
机构
[1] UNIV GRONINGEN,DEPT RADIOBIOL,NL-9713 BZ GRONINGEN,NETHERLANDS
[2] UNIV GRONINGEN,DEPT MED ONCOL,NL-9713 BZ GRONINGEN,NETHERLANDS
[3] UNIV GRONINGEN,DEPT HOSP PHARM,NL-9713 BZ GRONINGEN,NETHERLANDS
关键词
thermochemosensitization; cisplatin resistance; cisplatin accumulation; cisplatin-DNA adducts; adduct repair;
D O I
10.1038/bjc.1997.297
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDDP) sensitivity in cDDP-sensitive and -resistant cell lines of murine as well as human origin were investigated. Heating cells at 43 degrees C during cDDP exposure was found to increase drug accumulation significantly in the cDDP-resisiant cell lines but had little effect on drug accumulation in the cDDP-sensitive cell lines. DNA adduct formation, however, was significantly increased in all cell lines studied. Furthermore, ongoing formation of platinum (Pt)-DNA adducts after the end of cDDP treatment was enhanced and/or adduct removal was decreased in heated cells, resulting in relatively more DNA damage remaining at 24 h after the end of cDDP exposure. Correlation plots with survival revealed weak correlations with cellular Pi accumulation (r(2) = 0.59) and initial Pt-DNA adduct formation (r(2) = 0.64). Strong correlations, however, were found with Pt-DNA adducts at 6 h (r(2) = 0.97) and 24 h (r(2) = 0.89) after the incubation with the drug. In conclusion, the mechanism by which heat sensitizes cells for cDDP action seems to be the sum of multiple factors, which comprise heat effects on accumulation, adduct formation and adduct processing. This mechanism did not seem to differ between cDDP-sensitive and -resistant cells, emphasizing the potential of hyperthemia to reduce cDDP resistance.
引用
收藏
页码:1735 / 1743
页数:9
相关论文
共 50 条
  • [31] CHROMOSOMAL AND MUTATIONAL ANALYSIS OF THE CISPLATIN RESISTANT PHENOTYPE IN NSCLC CELLS
    Barr, Martin P.
    Alcock, Leah C.
    Stallings, Raymond L.
    Toomey, Sinead
    Carr, Aoife
    Hennessy, Bryan T.
    Richard, Derek
    O'Byrne, Kenneth
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S272 - S272
  • [32] RESTORATION OF CISPLATIN SENSITIVITY BY MILD HYPERTHERMIA IN RADIATION-INDUCED CISPLATIN-RESISTANT MOUSE FIBROSARCOMA CELLS
    EICHHOLTZWIRTH, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (04) : 935 - 939
  • [33] Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells
    Chun, Jaemoo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [34] Poncirin downregulatesATP-binding cassette transporters to enhance cisplatin sensitivity in cisplatin-resistant osteosarcoma cells
    Zhao, Liujing
    Zhang, Weiwei
    Zhang, Fang
    PHYTOTHERAPY RESEARCH, 2021, 35 (01) : 278 - 288
  • [35] Delineation of proapoptotic signaling of anthracene-shelled M2L4 metallacapsules and their synergistic activity with curcumin in cisplatin-sensitive and resistant tumor cell lines
    Mihaylova, Rositsa
    Ahmedova, Anife
    Momekova, Denitsa
    Momekov, Georgi
    Danchev, Nikolay
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (06) : 1117 - 1126
  • [36] Delineation of proapoptotic signaling of anthracene-shelled M2L4 metallacapsules and their synergistic activity with curcumin in cisplatin-sensitive and resistant tumor cell lines
    Rositsa Mihaylova
    Anife Ahmedova
    Denitsa Momekova
    Georgi Momekov
    Nikolay Danchev
    Investigational New Drugs, 2019, 37 : 1117 - 1126
  • [37] Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells
    Zhang, Ruitao
    Shi, Huirong
    Ren, Fang
    Li, Xia
    Zhang, Minghui
    Feng, Wei
    Jia, Yanyan
    ONCOLOGY REPORTS, 2016, 35 (04) : 2466 - 2472
  • [38] Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin-resistant ovarian cancer (A2780) cells
    Sarkhosh-Inanlou, Roya
    Molaparast, Morteza
    Mohammadzadeh, Adel
    Shafiei-Irannejad, Vahid
    CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 95 (02) : 215 - 223
  • [39] Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
    Huang, Wei
    Zhou, Quan
    Yuan, Xia
    Ge, Ze-mei
    Ran, Fu-xiang
    Yang, Hua-yu
    Qiang, Guang-liang
    Li, Run-tao
    Cui, Jing-rong
    JOURNAL OF CANCER, 2016, 7 (09): : 1133 - 1141
  • [40] Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1/DDP Nasopharyngeal Cancer Cells
    Wang, X.
    Zhang, J. -J.
    Sun, Y. -M.
    Zhang, J.
    Wang, L. -R.
    Li, J. -C.
    Liu, H.
    FOLIA BIOLOGICA, 2015, 61 (05) : 195 - 202